Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting

Hao Wang(East China University of Technology), Terry Roemer(Merck Canada Inc. (Canada)), Christopher M. Barbieri(Merck & Co., Inc., Rahway, NJ, USA (United States)), Megan D. McCurry(Harvard University), Xinwei Sher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Matthias Mack(Mannheim University of Applied Sciences), Artjohn Villafania(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew Galgoci(Merck & Co., Inc., Rahway, NJ, USA (United States)), John A. Howe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amy Flattery(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul A. Mann(Merck & Co., Inc., Rahway, NJ, USA (United States)), Todd Mayhood(Merck & Co., Inc., Rahway, NJ, USA (United States)), Li Xiao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Juliana C. Malinverni(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles Gill(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cell chemical biology
April 20, 2017
Cited by 92


Related Papers